Search Bio News Net


Free Biology Newsletter

This is a biology-specific news aggregator linking to the most recent copyrighted news and articles on popular websites. Our sources
November 06, 2012

HIV Vaccine Safe Enough To Pass Phase 1 Human Trials

Slashdot: Science - Fetched: November 6th, 2012, 9:00pm EST
An anonymous reader sends this excerpt from Western University in Canada: "The first human applied clinical study (SAV CT 01) using a genetically modified killed whole-virus vaccine (SAV001-H) to evaluate its safety and tolerability was initiated in March 2012. This study is a randomized, observer-blinded, placebo-controlled study of killed whole HIV-1 vaccine (SAV001-H) following intramuscular (IM) administration. Infected men and women, 18-50 years of age, have been enrolled in this study and randomized into two treatment groups to administer killed whole HIV-1 vaccine (SAV001-H) or placebo. Sumagen announced today the patient enrollment has progressed smoothly and there have been no adverse effects observed including local reactions, signs/symptoms and laboratory toxicities after SAV001-H injection in all enrolled patients to date. With these interim results, the SAV001-H has proven safety and tolerability in humans and given Sumagen confidence for the next clinical trials to prove its immunogenicity and efficacy evaluation."pdiv class="share_submission" style="position:relative;" a class="slashpop" href="http://twitter.com/home?status=HIV+Vaccine+Safe+Enough+To+Pass+Phase+1+Human+Trials%3A+http%3A%2F%2Fbit.ly%2FXhKxLN"img src="http://a.fsdn.com/sd/twitter_icon_large.png"/a a class="slashpop" href="http://www.facebook.com/sharer.php?u=http%3A%2F%2Fscience.slashdot.org%2Fstory%2F12%2F11%2F06%2F2325234%2Fhiv-vaccine-safe-enough-to-pass-phase-1-human-trials%3Futm_source%3Dslashdot%26utm_medium%3Dfacebook"img src="http://a.fsdn.com/sd/facebook_icon_large.png"/a a class="nobg" href="http://plus.google.com/share?url=http://science.slashdot.org/story/12/11/06/2325234/hiv-vaccine-safe-enough-to-pass-phase-1-human-trials?utm_source=slashdotamp;utm_medium=googleplus" onclick="javascript:window.open(this.href,'', 'menubar=no,toolbar=no,resizable=yes,scrollbars=yes,height=600,width=600');return false;"img src="http://www.gstatic.com/images/icons/gplus-16.png" alt="Share on Google+"//a /div/ppa href="http://science.slashdot.org/story/12/11/06/2325234/hiv-vaccine-safe-enough-to-pass-phase-1-human-trials?utm_source=rss1.0moreanonamp;utm_medium=feed"Read more of this story/a at Slashdot./p pa href="http://feedads.g.doubleclick.net/~at/WlQxN5QEwecZ929UMZiag7Wl5BE/0/da"img src="http://feedads.g.doubleclick.net/~at/WlQxN5QEwecZ929UMZiag7Wl5BE/0/di" border="0" ismap="true"/img/abr/ a href="http://feedads.g.doubleclick.net/~at/WlQxN5QEwecZ929UMZiag7Wl5BE/1/da"img src="http://feedads.g.doubleclick.net/~at/WlQxN5QEwecZ929UMZiag7Wl5BE/1/di" border="0" ismap="true"/img/a/pimg src="http://feeds.feedburner.com/~r/Slashdot/slashdotScience/~4/aKvSJewL6Zw" height="1" width="1"/

Read more

Return to the Newsfeed